Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Autops. Case Rep ; 11: e2021340, 2021. graf
Artigo em Inglês | LILACS | ID: biblio-1345359

RESUMO

Mantle cell lymphoma is characterized by t(11;14) with CCND1-IGH fusion and manifests with a spectrum of disease ranging from relatively indolent to aggressive. Here, we present a case of pleomorphic mantle cell lymphoma with three fusion signals that presented with lethal atraumatic splenic rupture. We discuss on the implications of variant CCND1 signal patterns as well as the epidemiology and pathophysiology of atraumatic splenic rupture.


Assuntos
Humanos , Masculino , Idoso , Ruptura Esplênica/patologia , Linfoma de Célula do Manto/epidemiologia , Esplenomegalia/complicações , Linfoma de Célula do Manto/fisiopatologia , Ciclina D
2.
Autops. Case Rep ; 9(3): e2019090, July-Sept. 2019. ilus, graf
Artigo em Inglês | LILACS | ID: biblio-1020995

RESUMO

Richter transformation (RT), or Richter syndrome, is defined as the transformation of chronic lymphocytic leukemia (CLL) to an aggressive B-cell lymphoma. The vast majority, up to 99%, transform into diffuse large B-cell lymphoma (DLBCL), with a small subset (<1%) becoming classical Hodgkin lymphoma. Approximately half of RT cases progress through a pathway involving dysregulation of C-MYC. High-grade B-cell lymphoma (HGBL) is a recent diagnostic category of aggressive B-cell lymphomas set forth in the updated 2017 WHO Classification of Hematopoietic and Lymphoid Tissues. HGBL with MYC and BCL2 and/or BCL6 rearrangements, formerly "double-hit" and "triple-hit" lymphomas, comprise the majority of HGBL cases. Patients with HGBL have a worse prognosis than those with diffuse large B-cell lymphoma. We present a case of RT with rearrangements of MYC and BCL6. To our knowledge, there are no reported cases of RT with a "double-hit" lymphoma genotype.


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Linfoma Difuso de Grandes Células B/patologia , Linfoma não Hodgkin , Leucemia Linfocítica Crônica de Células B , Citogenética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA